Abbott Laboratories Q2 Preview: Analysts Expect Growth from Exact Sciences Acquisition

Analysts are anticipating healthy growth for Abbott Laboratories in its Q2 earnings, with expectations largely backed by the recent acquisition of Exact Sciences. The acquisition is projected to contribute positively to the company's financial performance.